SCHEMBL9687808

SCHEMBL9687808

CN(C)CCc1cc([N+](=O)[O-])c2[nH]ncc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 4/20 0.47
MAPT P10636 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP3A4 P08684 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP1A2 P05177 1/20 0.47
THRB P10828 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
APEX1 P27695 1/20 0.47
NOS3 P29474 1/20 0.47
CYP2C19 P33261 1/20 0.47
NOS2 P35228 1/20 0.47
RECQL P46063 1/20 0.47
BLM P54132 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9689902 0.79 CHEK1 (0.35) NOS1MAPTNOS3NOS2ROCK2
SCHEMBL9689187 0.76 ROCK2 (0.37) ROCK2ROCK1
SCHEMBL3012819 0.74 MAPT (0.57) NOS1MAPTSMN1; SMN2CYP3A4NPSR1
SCHEMBL11576616 0.72 MAPT (0.58) NOS1MAPTSMN1; SMN2CYP3A4NPSR1
SCHEMBL25174769 0.71 NOS1 (0.57) NOS1MAPTSMN1; SMN2CYP3A4NPSR1
SCHEMBL31162483 0.71 NOS1 (0.57) NOS1MAPTSMN1; SMN2CYP3A4NPSR1
SCHEMBL27139677 0.71 NOS1 (0.57) NOS1MAPTSMN1; SMN2CYP3A4NPSR1
SCHEMBL9689830 0.71 MAPT (0.47) NOS1MAPTSMN1; SMN2CYP3A4NPSR1
SCHEMBL9689819 0.71 MAPT (0.47) NOS1MAPTSMN1; SMN2CYP3A4NPSR1
SCHEMBL9688419 0.71 SMN1; SMN2 (0.43) NOS1MAPTSMN1; SMN2CYP3A4NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0189473-B1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS SCHERING AKTIENGESELLSCHAFT (DE) 1992-05-27 EP disclosed
US-4958026-A HYPOTENSIVE AGENTS SCHERING AKTIENGESLLSCHAFT (DE) 1990-09-18 US disclosed
EP-0189473-A1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS. SCHERING AG (DE) 1986-08-06 EP disclosed
WO-1986001204-A1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS SCHERING AKTIENGESELLSCHAFT (DE) 1986-02-27 WO disclosed